KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $1.08.

  • Bristol Myers Squibb's EPS (Basic) rose 8000.0% to $1.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.97, marking a year-over-year increase of 18272.98%. This contributed to the annual value of -$4.41 for FY2024, which is 21365.98% down from last year.
  • Bristol Myers Squibb's EPS (Basic) amounted to $1.08 in Q3 2025, which was up 8000.0% from $0.64 recorded in Q2 2025.
  • Bristol Myers Squibb's EPS (Basic)'s 5-year high stood at $1.21 during Q1 2025, with a 5-year trough of -$5.89 in Q1 2024.
  • Its 5-year average for EPS (Basic) is $0.45, with a median of $0.83 in 2024.
  • In the last 5 years, Bristol Myers Squibb's EPS (Basic) soared by 127500.0% in 2021 and then tumbled by 64537.04% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's EPS (Basic) stood at $1.07 in 2021, then dropped by 10.28% to $0.96 in 2022, then decreased by 9.38% to $0.87 in 2023, then crashed by 95.4% to $0.04 in 2024, then surged by 2600.0% to $1.08 in 2025.
  • Its EPS (Basic) stands at $1.08 for Q3 2025, versus $0.64 for Q2 2025 and $1.21 for Q1 2025.